Diagnosis and treatment of growth hormone deficiency in adults (Q38102923)

28 August 2017

Diagnosis and treatment of growth hormone deficiency in adults (English)

1 reference

growth hormone deficiency

28 August 2017

1 reference

Atil Y Kargi

1

1 reference

PubMed ID

23629539

28 August 2017

George R Merriam

series ordinal

2

1 reference

28 August 2017

30 April 2013

1 reference

Nature Reviews Endocrinology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

335-345

1 reference

28 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.77

28 August 2017

0 references

cites work

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Recent advances in growth hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The somatomedin hypothesis: 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Nutritional regulation of IGF-I and IGF binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effect of growth hormone on carbohydrate and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone and protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

21 January 2018

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

A METABOLIC REGULATING DEVICE BASED ON THE ACTIONS OF HUMAN GROWTH HORMONE AND OF INSULIN, SINGLY AND TOGETHER, ON THE HUMAN FOREARM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Incidence of growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

GH deficiency in adults: an epidemiological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Incidence of GH deficiency - a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

21 January 2018

12 December 2020

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Pituitary function in subjects with mild traumatic brain injury: a review of literature and proposal of a screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Anterior pituitary dysfunction in survivors of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Prevalence and predictive factors of post-traumatic hypopituitarism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The current status of IGF-I assays--a 2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Testing for growth hormone deficiency in adults: doing without growth hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Hazards of pharmacological tests of growth hormone secretion in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The growth hormone deficiency syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Reduced bone mineral density in patients with adult onset growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Increased fracture frequency in adult patients with hypopituitarism and GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone-deficient adults are insulin-resistant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Pharmacologic therapy in growth hormone disorders and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Factors influencing the desire for long-term growth hormone replacement in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Mortality in patients with pituitary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Mortality and reduced growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Mortality and GH deficiency: a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Transitioning of children with GH deficiency to adult dosing: changes in body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Influences on quality of life in GH deficient adults and their effect on response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Increased mortality associated with growth hormone treatment in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Which adults develop side-effects of growth hormone replacement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone. 1. Physiologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Reduced bone mineral content in adult patients with growth hormone deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Consequences of childhood-onset growth hormone deficiency for adult bone mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Serum lipid levels in growth hormone-deficient men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Ten Years of Growth Hormone (GH) Replacement Normalizes Muscle Strength in GH-Deficient Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.77

Diagnosis of severe growth hormone (GH) deficiency in young adults who received GH replacement therapy during childhood

31 March 2020

1 reference

12 December 2020

Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.

1 reference

12 December 2020

Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.

1 reference

12 December 2020

Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?

1 reference

12 December 2020

Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults

1 reference

12 December 2020

The diagnosis and treatment of growth hormone deficiency in adults

1 reference

12 December 2020

Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood

1 reference

12 December 2020

The effects of growth hormone on cortical and cancellous bone

1 reference

12 December 2020

Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study

1 reference

12 December 2020

Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

1 reference

12 December 2020

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

1 reference

12 December 2020

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy

1 reference

12 December 2020

The effect of hypopituitarism on life expectancy

1 reference

12 December 2020

Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency

1 reference

12 December 2020

Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects

1 reference

12 December 2020

Metabolic consequences of GH deficiency.

1 reference

12 December 2020

Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.77

1 reference

PubMed ID

23629539

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23629539